D-4f Restores Proinflammatory Hdl Profiles Back To Anti-Inflammatory In Hypercholesterolemic Ldlr-/- Mice

jingsong ou,hao xu,zhijun ou,papaekow coleman,rong ying,dade huang,keith t oldham

DOI: https://doi.org/10.1096/fasebj.22.1_supplement.924.6

2008-01-01

Abstract:D-4F, an apolipoprotein A-I (apoA-I) mimetic peptide, has been shown to improve high density lipoprotien (HDL) function. A recent report indicated HDL proteomics were different between healthy and hypercholesterolemia (HC) patients. To test if D-4F changes the HDL proteomics, low density lipoprotein receptor-null (LDLr−/−) mice were fed western diet ±D-4F for 12 weeks. ApoA-I was immunoprecipitated from mice plasma and the protein composition analyzed by 2-D gel electrophoresis and nano-LC/MS. We observed the 2-D gel patterns were different among the different groups. The 2-D gel patterns between control (C) and HC + D-4F were similar, which were both different from HC alone. More than 200 proteins in each group were identified by nano-LC/MS. More proteins were common between C and HC + D-4F than between C or HC + D-4F and HC. The concentration of atherogenic proteins such as apolipoprotein E and apolipoprotein C IV, was higher in HC than C or HC + D-4F. More complement proteins (C4, C1q, factor B) were observed in HC than in C and HC + D-4F. Western blot analysis confirmed proteomics findings. Our data indicate HC shifts HDL proteomics to a profile that is proatherogenic and D-4F shift the profile to an anti-atherogenic profile. These provide new insight into how HC impairs HDL function by allowing atherogenic proteins to bind to the HDL particle and how D-4F improves HDL function by inhibiting binding of atherogenic proteins.